Clinical trial · Interventional
A Study to Assess the Efficiency of Trastuzumab Deruxtecan in Russian Breast Cancer Patients
NCT07281001CI-TRIAL-00098963TraderrusrecruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This multi-center observational retrospective study will collect real-world clinical data from eligible patients with unresectable or metastatic HER2+ breast cancer who have received one or more cycles Trastuzumab Deruxtecan in Russian Federation
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HER2-positive Breast Cancer | HER2-Positive Breast Carcinoma | ALIAS | 0.90 |
| Trastuzumab Deruxtecan | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| T-DXd 5.4 mg/kg, IVD, 1 cycle every 21 days. | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Patients with unresectable or metastatic HER2+ BC who have received one or more cycles T-DXd
- interventionNames
- Drug: T-DXd 5.4 mg/kg, IVD, 1 cycle every 21 days.
Primary outcomes (1)
- measure
- PFS
- timeFrame
- 6 weeks
- description
- progression-free survival
Secondary outcomes (4)
- measure
- ORR
- timeFrame
- 6 weeks
- description
- Overall Response Rate
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients aged over 18 years old. 2. Metastatic breast cancer included unresectable locally advanced breast cancer, de novo stage IV breast cancer, and recurrent metastatic breast cancer. 3. Patients has received Trastuzumab Deruxtecan 4. Available medical history. Exclusion Criteria: 1. Incomplete medical history. 2. Pregnancy or breast-breeding
References
Publications (0)
Data not yet available
No reference posted for this study.